Agenus Inc. (AJ8)
FSX
Real-time Data
06:00 AM
Day's Range
6.8052 wk Range
2.30Overview - AJ8 - Agenus Inc.
Key Statistics
Valuation
Enterprise Value
277.10M
P/E (Trailing)
‪2.67‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪2.32‬
Price / Book
‪-1.36‬
EV / EBITDA
‪7.96‬
Profitability
Gross Margin
‪57.24%‬
Profit Margin
‪69.34%‬
Operating Margin
‪32.71%‬
Return on Assets
‪12.53%‬
Return on Equity
‪0.03%‬
Ownership
Shares Outstanding
44.75M
Float
40.23M
Held by Insiders
‪6.22%‬
Held by Institutions
‪45.94%‬
Price stats
Beta
‪1.39‬
50-Day Avg
‪4.53‬
200-Day Avg
‪3.39‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - AJ8 - Agenus Inc.
Peers - AJ8 - Agenus Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- AJ8FSXAgenus Inc.285.81MMarket Cap+38.90%52-week change2.46P/E (Trailing)‪69.34%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+81.89%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - AJ8 - Agenus Inc.
About
Agenus Inc. is a clinical-stage biotechnology company focused on immuno-oncology and the development of therapies designed to activate the immune system against cancer. The company’s current work centers on antibody-based therapeutics, immune checkpoint modulators, cell therapies, vaccines, and vaccine adjuvants,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
